ANLN and glioblastoma: Further analysis using the “CPTAC Analysis” confirmed ANLN overexpression in BRCA, renal cell carcinoma, COAD, HNSC, LIHC, LUAD, OV, PAAD, and UCEC tumors compared with in normal tissues; however, there was low ANLN expression in the glioblastoma multiforme (Figure 3B).